SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-042052
Filing Date
2024-04-05
Accepted
2024-04-05 06:06:17
Documents
23
Period of Report
2024-05-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A mnkd-20240405.htm   iXBRL DEF 14A 1662791
2 GRAPHIC img30985660_0.jpg GRAPHIC 605475
3 GRAPHIC img30985660_1.jpg GRAPHIC 27243
4 GRAPHIC img30985660_2.jpg GRAPHIC 27243
5 GRAPHIC img30985660_3.jpg GRAPHIC 5041
6 GRAPHIC img30985660_4.jpg GRAPHIC 5890
7 GRAPHIC img30985660_5.jpg GRAPHIC 7428
8 GRAPHIC img30985660_6.jpg GRAPHIC 31932
9 GRAPHIC img30985660_7.jpg GRAPHIC 27590
10 GRAPHIC img30985660_8.jpg GRAPHIC 28203
11 GRAPHIC img30985660_9.jpg GRAPHIC 5041
12 GRAPHIC img30985660_10.jpg GRAPHIC 125853
13 GRAPHIC img30985660_11.jpg GRAPHIC 114395
  Complete submission text file 0000950170-24-042052.txt   5220317

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20240405.xsd EX-101.SCH 82502
26 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20240405_htm.xml XML 229665
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50865 | Film No.: 24824673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)